Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
National Committee for Clinical Laboratory Standards.
Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. 1997., (1997),
[2.]
F. Laguna, J.L. Rodriguez-Tudela, J.V. Martinez-Suarez, R. Polo, E. Valencia, T.M. Diaz-Guerra, et al.
Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Clin Infect Dis, 24 (1997), pp. 124-130
[3.]
J.H. Rex, M.A. Pfaller, A.L. Barry, P.W. Nelson, C.D. Webb.
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Antimicrob Agents Chemother, 39 (1995), pp. 40-44
[4.]
J.H. Rex, M.A. Pfaller, T.J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M.A. Ghannoum, et al.
Antifungal susceptibility testing: Practical aspects and current challenges.
Clin Microbiol Rev, 14 (2001), pp. 643-658
[5.]
J.L. Rodriguez-Tudela, J.V. Martinez-Suarez, F. Dronda, F. Laguna, F. Chaves, E. Valencia.
Correlation of in-vitro susceptibility test results with clinical response: A study of azole therapy in AIDS patients.
J Antimicrob Chemother, 35 (1995), pp. 793-804
[6.]
M.A. Pfaller, R.N. Jones, G.V. Doern, H.S. Sader, R.J. Hollis, S.A. Messer.
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
J Clin Microbiol, 36 (1998), pp. 1886-1889
[7.]
M.A. Pfaller, R.N. Jones, G.V. Doern, A.C. Fluit, J. Verhoef, H.S. Sader, et al.
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagn Microbiol Infect Dis, 35 (1999), pp. 19-25
[8.]
M.A. Pfaller, R.N. Jones, G.V. Doern, H.S. Sader, S.A. Messer, A. Houston, et al.
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
Antimicrob Agents Chemother, 44 (2000), pp. 747-751
[9.]
M.S. Rangel-Frausto, T. Wiblin, H.M. Blumberg, L. Saiman, J. Patterson, M. Rinaldi, et al.
National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.
Clin Infect Dis, 29 (1999), pp. 253-258
[10.]
J.L. Rodriguez-Tudela, M. Cuenca-Estrella.
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Rev Clin Esp, 199 (1999), pp. 356-361
[11]
National Committee for Clinical Laboratory Standards.
Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. M38-P., (1998),
[12.]
J.H. Rex, M.A. Pfaller, J.N. Galgiani, M.S. Bartlett, A. Espinel-Ingroff, M.A. Ghannoum, et al.
Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clin Infect Dis, 24 (1997), pp. 235-247
[13.]
M. Cuenca-Estrella, T.M. Diaz-Guerra, E. Mellado, J.L. Rodriguez-Tudela.
Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.
J Clin Microbiol, 39 (2001), pp. 525-532
[14.]
J.H. Rex, C.R. Cooper Jr, W.G. Merz, J.N. Galgiani, E.J. Anaissie.
Detection of amphotericin B-resistant Candida isolates in a broth-based system.
Antimicrob Agents Chemother, 39 (1995), pp. 906-909
[15.]
M. Cuenca-Estrella, T.M. Diaz-Guerra, E. Mellado, J.L. Rodriguez-Tudela.
Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth.
Antimicrob Agents Chemother, 45 (2001), pp. 2070-2074
[16.]
M.H. Nguyen, C.J. Clancy, V.L. Yu, Y.C. Yu, A.J. Morris, D.R. Snydman, et al.
Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.
J Infect Dis, 177 (1998), pp. 425-430
[17.]
L.R. Peterson, C.J. Shanholtzer.
Tests for bactericidal effects of antimicrobial agents: Technical performance and clinical relevance.
Clin Microbiol Rev, 5 (1992), pp. 420-432
[18]
Williams & Wilkins, (2001),
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
